Evidence map›Paper›PMID 35692340›Full record

ArticleFrontiers in public health2022

The WHO-ITU MyopiaEd Programme: A Digital Message Programme Targeting Education on Myopia and Its Prevention.

Stuart Keel, Pirindha Govender-Poonsamy, Alarcos Cieza, Hannah Faal, Ian Flitcroft, Kate Gifford, Mingguang He, Rajiv Khandekar, Kovin Naidoo, Matt Oerding and 8 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Development of a text message intervention designed to promote safe contact lens wear.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stuart KeelDepartment of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Pirindha Govender-PoonsamyAfrican Vision Research Institute, University of KwaZulu Natal, Durban, South Africa.
Alarcos CiezaDepartment of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Hannah FaalAfrican Vision Research Institute, University of KwaZulu Natal, Durban, South Africa.
Ian FlitcroftCentre for Eye Research, Dublin, Ireland.
Kate GiffordMyopia Profile Pty, Ltd, Brisbane, QLD, Australia.
Mingguang HeDepartment of Optometry and Vision Sciences, University of Melbourne, Melbourne, VIC, Australia.
Rajiv KhandekarKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Kovin NaidooAfrican Vision Research Institute, University of KwaZulu Natal, Durban, South Africa.
Matt OerdingGlobal Myopia Awareness Coalition, Boulder, CO, United States.
Kyoko Ohno-MatsuiDepartment of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Silvio MariottiDepartment of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Christine WildsoetSchool of Optometry, University of California, Berkeley, Berkeley, CA, United States.
James S WolffsohnOptometry and Vision Science, Aston University, Birmingham, United Kingdom.
Tien Y WongSingapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Sangchul YoonDept of Medical Humanities and Social Sciences, Yonsei University, Seoul, South Korea.
Andreas MuellerDepartment of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Rosie DobsonNational Institute for Health Innovation, University of Auckland, Auckland, New Zealand.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The objective of this paper is to provide an overview of the World Health Organization - International Telecommunication Union MyopiaEd programme - a digital message programme targeting education on myopia and its prevention. The development of the MyopiaEd programme included 4 key steps: (1) Conceptualization and consultation with experts in the field of myopia, mHealth and health behavior change; (2) Creation of SMS message libraries and programme algorithm; (3) Review of the message libraries to ensure relevance to the target audience; and (4) Pre-testing amongst end-user groups to ensure that the design of the programme and the message content were understandable. After reviewing the available evidence and considering input of the experts, the aims, end users and key themes of the programme were finalized. Separate SMS-adapted message libraries were developed, reviewed and pre-tested for four target end-user groups; (1) general population involved in the care of children (2) parents or caregivers of children with myopia; (3) adolescents with myopia; and (4) adults with myopia. The message libraries are part of a comprehensive toolkit, developed through a consultative process with experts in digital health, to support implementation within countries. The development of the MyopiaEd programme aims to provide a basis for Member States and other stakeholders to develop, implement and monitor large-scale mHealth programmes. It is aimed at raising awareness of good eye care behaviors and addressing common reasons for non-compliance to spectacle wear. The next steps will involve adapting and evaluating the MyopiaEd programme in selected settings.

Indexed as

MyopiaTelemedicineAdolescentAdultCaregiversChildHumansParentsWorld Health Organizationbehavior changedigital healthmHealthmyopiapublic health

Identifiers

PMID35692340
PMCPMC9177978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.